Total Funding
1
Total FundingFunding Round raised
Growth Score
pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Early detection for Crohn's Disease
Guy Yachdav: Founder and Co-CEOPast Role: aiola, Head of Customer Delivery
Yana Bromberg: FounderPast Role: Rutgers University, Assistant Professor, Dept. of Biochemistry and Microbiology
About the Company
VariAD developed a unique patent-pending test to detect pre-disposition for Crohn’s Disease. The test, code named – deNoVA, analyzes the genetic makeup of the patient and determines the likelihood of the patient to develop Crohn’s as well as the severity level of the pre-disposition. Since this is a genetic test, samples are extracted from the
patient through a simple, non-invasive procedure. Evaluated by an independent panel using clinical data, the deNoVa tool demonstrated high-accuracy, correctly identifying 96% of Crohn's patients based on their genome data alone.
Women Founded
